Hahn NM, Powles T, Massard C, et al. Updated efficacy and tolerability of durvalumab in locally advanced or metastatic urothelial carcinoma (UC). J Clin Oncol. 2017;35 (suppl; abstr 4525).
Veelbelovend proefschrift over verbeteren immuuntherapie bekroond
nov 2023 | Immuuntherapie, Maag-darm-leveroncologie